Pohanka E - Search Results

1

Evidence that sensitivity to cyclosporine is influenced by the HLA-DR phenotype of kidney graft recipients.

Zlabinger GJ, Kudlacek S, Pohanka E, Franz M, Hamilton G, Rosenmayr A, Kovarik J. Zlabinger GJ, et al. Among authors: pohanka e. Transplantation. 1992 Apr;53(4):758-62. doi: 10.1097/00007890-199204000-00010. Transplantation. 1992. PMID: 1566340

2

Induction of an acute phase response after OKT3 therapy.

Pohanka E, Kovarik J, Klauser R, Woloszcsuk W, Zlabinger GJ. Pohanka E, et al. Transplant Proc. 1992 Feb;24(1):269-70. Transplant Proc. 1992. PMID: 1371618 No abstract available.

3

Evidence for granulocyte activation by OKT3.

Schmaldienst S, Böhmig G, Pohanka E, Kovarik J, Zlabinger GJ. Schmaldienst S, et al. Among authors: pohanka e. Transplant Proc. 1992 Dec;24(6):2600-1. Transplant Proc. 1992. PMID: 1465878 No abstract available.

4

High incidence of significant bacteriuria in kidney graft recipients with triple therapy.

Franz M, Traindl O, Pohanka E, Höbarth K, Simak R, Klauser R, Watschinger B, Kovarik J. Franz M, et al. Among authors: pohanka e. Transplant Proc. 1992 Feb;24(1):289-91. Transplant Proc. 1992. PMID: 1539282 Clinical Trial. No abstract available.

5

Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.

Klauser R, Zlabinger GJ, Traindl O, Franz M, Watschinger B, Pohanka E, Kudlacek S, Kovarik J. Klauser R, et al. Among authors: pohanka e. Transplant Proc. 1992 Feb;24(1):292-4. Transplant Proc. 1992. PMID: 1539284 Clinical Trial. No abstract available.

6

Immunologic monitoring in OKT3-treated kidney graft recipients.

Zlabinger GJ, Maurer D, Ulrich W, Meron G, Pohanka E, Kovarik J. Zlabinger GJ, et al. Among authors: pohanka e. Transplant Proc. 1990 Aug;22(4):1777-8. Transplant Proc. 1990. PMID: 2117807 No abstract available.

7

Interferon-gamma, neopterin, and interleukin-2 receptor levels in the serum of kidney transplant recipients.

Steiner G, Zlabinger G, Karamehic J, Pohanka E, Kovarik J, Woloszczuk W. Steiner G, et al. Among authors: pohanka e. Transplant Proc. 1990 Aug;22(4):1857-8. Transplant Proc. 1990. PMID: 2117813 No abstract available.

8

Influence of HLA phenotypes on the inhibition of in vitro alloreactivity by cyclosporine.

Zlabinger GJ, Pohanka E, Hajek-Rosenmayr A, Pavlicek E, Watschinger B, Traindl O, Kovarik J. Zlabinger GJ, et al. Among authors: pohanka e. Transplantation. 1990 Dec;50(6):1038-42. doi: 10.1097/00007890-199012000-00027. Transplantation. 1990. PMID: 2147791

9

Determination of serum OKT3 levels with flow cytometry.

Zlabinger GJ, Ulrich W, Sonnleitner A, Pohanka E, Traindl O, Kovarik J. Zlabinger GJ, et al. Among authors: pohanka e. Transplant Proc. 1989 Feb;21(1 Pt 1):989-91. Transplant Proc. 1989. PMID: 2650304 No abstract available.

10

OKT3 monoclonal antibody treatment in renal transplant recipients--clinical experience in 49 patients.

Kovarik J, Zlabinger GJ, Wolfram J, Pecherstorfer M, Watschinger B, Traindl O, Pohanka E, Sonnleitner A, Ulrich W. Kovarik J, et al. Among authors: pohanka e. Transplant Proc. 1989 Feb;21(1 Pt 2):1748-52. Transplant Proc. 1989. PMID: 2652572 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters